BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15924884)

  • 1. Comparison of supervised clustering methods to discriminate genotoxic from non-genotoxic carcinogens by gene expression profiling.
    van Delft JH; van Agen E; van Breda SG; Herwijnen MH; Staal YC; Kleinjans JC
    Mutat Res; 2005 Aug; 575(1-2):17-33. PubMed ID: 15924884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the expression profiles induced by genotoxic and nongenotoxic carcinogens in rat liver.
    Ellinger-Ziegelbauer H; Stuart B; Wahle B; Bomann W; Ahr HJ
    Mutat Res; 2005 Aug; 575(1-2):61-84. PubMed ID: 15890375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of potential biomarkers of genotoxicity and carcinogenicity in L5178Y mouse lymphoma cells by cDNA microarray analysis.
    Kim JY; Kwon J; Kim JE; Koh WS; Chung MK; Yoon S; Song CW; Lee M
    Environ Mol Mutagen; 2005; 45(1):80-9. PubMed ID: 15612046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-class clustering and prediction in the analysis of microarray data.
    Tsai CA; Lee TC; Ho IC; Yang UC; Chen CH; Chen JJ
    Math Biosci; 2005 Jan; 193(1):79-100. PubMed ID: 15681277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of hepatocarcinogen-induced gene expression profiles in conventional primary rat hepatocytes with in vivo rat liver.
    Doktorova TY; Ellinger-Ziegelbauer H; Vinken M; Vanhaecke T; van Delft J; Kleinjans J; Ahr HJ; Rogiers V
    Arch Toxicol; 2012 Sep; 86(9):1399-411. PubMed ID: 22484513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of chlorpromazine with and without UV irradiation on gene expression of HepG2 cells.
    Frötschl R; Weickardt S; Staszewski S; Kaufmann G; Kasper P
    Mutat Res; 2005 Aug; 575(1-2):47-60. PubMed ID: 15924885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrimination for genotoxic and nongenotoxic carcinogens by gene expression profiling in primary mouse hepatocytes improves with exposure time.
    Mathijs K; Brauers KJ; Jennen DG; Boorsma A; van Herwijnen MH; Gottschalk RW; Kleinjans JC; van Delft JH
    Toxicol Sci; 2009 Dec; 112(2):374-84. PubMed ID: 19770486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in gene expression profiles in the liver between carcinogenic and non-carcinogenic isomers of compounds given to rats in a 28-day repeat-dose toxicity study.
    Nakayama K; Kawano Y; Kawakami Y; Moriwaki N; Sekijima M; Otsuka M; Yakabe Y; Miyaura H; Saito K; Sumida K; Shirai T
    Toxicol Appl Pharmacol; 2006 Dec; 217(3):299-307. PubMed ID: 17070881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in projecting clustering results across gene expression-profiling datasets.
    Lusa L; McShane LM; Reid JF; De Cecco L; Ambrogi F; Biganzoli E; Gariboldi M; Pierotti MA
    J Natl Cancer Inst; 2007 Nov; 99(22):1715-23. PubMed ID: 18000217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrimination of genotoxic and non-genotoxic hepatocarcinogens by statistical analysis based on gene expression profiling in the mouse liver as determined by quantitative real-time PCR.
    Watanabe T; Suzuki T; Natsume M; Nakajima M; Narumi K; Hamada S; Sakuma T; Koeda A; Oshida K; Miyamoto Y; Maeda A; Hirayama M; Sanada H; Honda H; Ohyama W; Okada E; Fujiishi Y; Sutou S; Tadakuma A; Ishikawa Y; Kido M; Minamiguchi R; Hanahara I; Furihata C
    Mutat Res; 2012 Sep; 747(2):164-75. PubMed ID: 22634710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of a carcinogenic potential of rat hepatocarcinogens using toxicogenomics analysis of short-term in vivo studies.
    Ellinger-Ziegelbauer H; Gmuender H; Bandenburg A; Ahr HJ
    Mutat Res; 2008 Jan; 637(1-2):23-39. PubMed ID: 17689568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporating gene functions as priors in model-based clustering of microarray gene expression data.
    Pan W
    Bioinformatics; 2006 Apr; 22(7):795-801. PubMed ID: 16434443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling in primary mouse hepatocytes discriminates true from false-positive genotoxic compounds.
    Mathijs K; Brauers KJ; Jennen DG; Lizarraga D; Kleinjans JC; van Delft JH
    Mutagenesis; 2010 Nov; 25(6):561-8. PubMed ID: 20650930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of basal gene expression profiles and effects of hepatocarcinogens on gene expression in cultured primary human hepatocytes and HepG2 cells.
    Harris AJ; Dial SL; Casciano DA
    Mutat Res; 2004 May; 549(1-2):79-99. PubMed ID: 15120964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detecting biological associations between genes based on the theory of phase synchronization.
    Kim CS; Riikonen P; Salakoski T
    Biosystems; 2008 May; 92(2):99-113. PubMed ID: 18289772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of different stress pathways after styrene and styrene-7,8-oxide exposure in HepG2 cell line and normal human hepatocytes.
    Diodovich C; Urani C; Maurici D; Malerba I; Melchioretto P; Orlandi M; Zoia L; Campi V; Carfi' M; Pellizzer C; Gribaldo L
    J Appl Toxicol; 2006; 26(4):317-25. PubMed ID: 16705669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissecting modes of action of non-genotoxic carcinogens in primary mouse hepatocytes.
    Schaap MM; Zwart EP; Wackers PF; Huijskens I; van de Water B; Breit TM; van Steeg H; Jonker MJ; Luijten M
    Arch Toxicol; 2012 Nov; 86(11):1717-27. PubMed ID: 22710402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.
    Fulci V; Colombo T; Chiaretti S; Messina M; Citarella F; Tavolaro S; Guarini A; Foà R; Macino G
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1069-82. PubMed ID: 19760605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification.
    Jennen DG; Magkoufopoulou C; Ketelslegers HB; van Herwijnen MH; Kleinjans JC; van Delft JH
    Toxicol Sci; 2010 May; 115(1):66-79. PubMed ID: 20106945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of early target genes of aflatoxin B1 in human hepatocytes, inter-individual variability and comparison with other genotoxic compounds.
    Josse R; Dumont J; Fautrel A; Robin MA; Guillouzo A
    Toxicol Appl Pharmacol; 2012 Jan; 258(2):176-87. PubMed ID: 22100608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.